SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-018633
Filing Date
2018-08-02
Accepted
2018-08-02 06:06:49
Documents
60
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbph-10q_20180630.htm 10-Q 1360440
2 EX-31.1 sbph-ex311_8.htm EX-31.1 23506
3 EX-31.2 sbph-ex312_7.htm EX-31.2 23083
4 EX-32.1 sbph-ex321_6.htm EX-32.1 16340
  Complete submission text file 0001564590-18-018633.txt   6084921

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sbph-20180630.xml EX-101.INS 1481228
6 XBRL TAXONOMY EXTENSION SCHEMA sbph-20180630.xsd EX-101.SCH 43348
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbph-20180630_cal.xml EX-101.CAL 42704
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbph-20180630_def.xml EX-101.DEF 142548
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbph-20180630_lab.xml EX-101.LAB 343002
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbph-20180630_pre.xml EX-101.PRE 266132
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37718 | Film No.: 18986498
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1